The medical profession may again be forced to face the limelight after the Securities and Exchange Commission revoked the corporate registration of a group promoting stem cell therapy allegedly due to a falsified document.
http://ift.tt/1da0pUU
http://ift.tt/1da0pUU
No comments:
Post a Comment